Previous Close | 22.40 |
Open | 22.37 |
Bid | 22.15 x 1100 |
Ask | 0.00 x 800 |
Day's Range | 22.35 - 22.68 |
52 Week Range | 19.34 - 23.79 |
Volume | |
Avg. Volume | 71,720 |
Market Cap | 80.057B |
Beta (5Y Monthly) | 1.42 |
PE Ratio (TTM) | 0.44 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.52 (6.75%) |
Ex-Dividend Date | Apr 24, 2024 |
1y Target Est | N/A |
Ms. Salka brings more than 30 years of healthcare leadership and staffing expertise, including strong C-suite, financial and ESG expertise to advance the company’s Patients-first focus and growth initiativesDURHAM, N.C., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the appointment of Susan R. Salka, retired Chief Executive Officer and President
DirectBooks, a global leader in primary markets communications, announced today that Santander, Ramirez & Co. and Mischler Financial Group have joined the platform. The recent additions increase the number of underwriters participating on DirectBooks to 34 worldwide.
Elwood Technologies LLP ("Elwood" or "the Company"), a leading software-as-a-service ("SaaS") platform that provides institutional-grade access to digital asset exchanges and liquidity venues, today announced it has been authorised as a service company by the UK Financial Conduct Authority ("FCA"). This authorization applies to Elwood's execution management system ("EMS") in relation to security tokens and derivatives. The Company's EMS platform allows clients to connect to global crypto exchang